Article
Natural CD4+ T-Cell Responses against Indoleamine 2,3-Dioxygenase
23 Apr 2012
Abstract excerpt
BACKGROUND: The enzyme indoleamine 2,3-dioxygenase (IDO) contributes to immune tolerance in a variety of settings. In cancer IDO is expressed within the tumor itself as well as in antigen-presenting cells in tumor-draining lymph nodes, where it endorses the establishment of peripheral immune tolerance to tumor antigens. Recently, we described cytotoxic CD8(+) T-cell reactivity towards IDO-derived peptides....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
